Companies /Healthcare

Atricure Inc

NASDAQ: ATRC Medical Instruments & Supplies
$54.64
▲ $1.68 (+3.17%) today
Markets open · 4:12pm ET
Today · % change

Fundamentals

Market Cap
$2.7B
P/E Ratio
252.2
Profit Margin
1.9%
Revenue (TTM)
$569.6M
EPS (TTM)
$0.21
52-Week Range
$25 – $56
Street Target
$51.67

About AtriCure

AtriCure, Inc. specializes in creating and distributing innovative devices aimed at the surgical treatment of cardiac conditions. Their product lineup includes devices for cardiac tissue ablation, left atrial appendage exclusion, and nerve ablation for pain management. Notable offerings include the Isolator Synergy Clamps, multifunctional pens like the MAX Pen for cardiac arrhythmias, and the Coolrail device for extended linear ablations. They also offer the cryoICE Cryoablation System for linear ablations, EPi-Sense Systems for atrial fibrillation treatment, and the AtriClip System for soft-tissue closure. AtriCure markets its products globally, serving medical centers through direct sales and distributors. Headquartered in Mason, Ohio, the company was founded in 2000.

ATRC Coverage